A while ago we announced the appointment of Michelle Hoffman as Editorial Director of Advanstar’s Pharmaceutical Drug Development and Manufacturing Group, which now includes BioPharm International along with Pharmaceutical Technology and the IVT Journals. The reorganization allows us to leverage all of our assets in the US and abroad to expand our editorial breadth and geographic presence.

BioPharm will soon have a European bureau, whose editors will source the best manuscripts from European industrial scientists and academics. In addition, BioPharm will benefit from Advanstar’s Drug Development and Manurfacturing Group’s extensive network of reporters. Located in South America, Europe, India, and East Asia these writers will deliver BioPharm’s readers the most important breaking news and business trends anywhere in the world.

With advanced training in molecular biology, an MBA in corporate finance and entrepreneurship, and years of experience in the pharmaceutical and biotech industries, Ms. Hoffman will lead the publication to produce the best, most useful blend of cutting edge technology and business news that will guide readers’ efforts as their products become more complex and as they operate in an increasingly difficult business and regulatory climate.

Our former Editor-In –Chief Laura Bush moves over as Editorial Director of two of our most prestigious and successful publications LCGC and Spectroscopy magazines.

I will update you as to other improvements we are planning for our print and electronic products for 2011 in future correspondence. Please contact me with any questions or comments you may have re: BioPharm International. Thank you for your support, I look forward to working with you for a successful 2011. 

Sincerely,
Pat Venezia Jr.
Associate Publisher BioPharm Interenational
732 346 3011
pvenezia@advanstar.com
www.biopharminternational.com